Tag: sarcoma
SOT106: An LRRC15-Directed ADC Moves Toward the Clinic in Sarcoma
SOT106, an investigational antibody-drug conjugate directed against leucine-rich repeat-containing 15 (LRRC15), is moving toward first-in-human testing after receiving four U.S. Food and Drug Administration...
University of Copenhagen’s Spin-out company ADCendo to Explore and Commercialize Novel...
Earlier this year spin-out company ADCendo, the University of Copenhagen and the Capital Region of Denmark entered into a worldwide license agreement to develop...
